| Date | Form | Description | Docs | XBRL | Pages |
| 03/17/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
47 | |
| 03/10/10 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
8 | |
| 03/10/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
80 | |
| 02/23/10 | UPLOAD | SEC-generated letter |
|
5 | |
| 01/29/10 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
121 | |
| 12/11/09 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/11/09 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/30/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/13/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 10/13/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
Read More...Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Read More...